Biodegradation, biocompatibility, and osteoconduction evaluation of collagen-nanohydroxyapatite cryogels for bone tissue regeneration

Journal of Biomedical Materials Research - Part A

Volumn 104, Issue 1, 2016, Pages 57-70

  Salgado, Christiane Laranjo ^a,b,c   Grenho, Liliana ^a,b,c   Fernandes, Maria Helena ^d   Colaço, Bruno Jorge ^e   Monteiro, Fernando Jorge ^a,b,c  

^a UNIVERSITY OF PORTO   (Portugal)

^b INEB INSTITUTO DE ENGENHARIA BIOMÉDICA   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d U Porto   (Portugal)

^e UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

Author keywords

biomimetic material; bone regeneration; collagen; nanohydroxyapatite

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADATION; BIOMIMETIC MATERIALS; BIOMIMETICS; BIOMINERALIZATION; BONE; CELL PROLIFERATION; COLLAGEN; COMPOSITE MATERIALS; DEFECTS; DEGRADATION; MICROBIOLOGY; PHOSPHATE MINERALS; TISSUE;

BIOCOMPOSITE MATERIALS; BIOMINERALIZATION PROCESS; BONE REGENERATION; BONE TISSUE REGENERATION; CLINICAL APPLICATION; HUMAN BONE MARROW STROMAL CELLS (HBMSC); NANO-HYDROXYAPATITE; SIMULATED BODY FLUIDS;

TISSUE REGENERATION;

ALKALINE PHOSPHATASE; APATITE; COLLAGEN; COLLAGEN SPONGE; HYDROXYAPATITE; NANOHYDROXYAPATITE; UNCLASSIFIED DRUG; BIOMATERIAL; CRYOGEL; NANO-HYDROXYAPATITE-COLLAGEN;

ADVERSE OUTCOME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIODEGRADATION; BODY FLUID; BONE CONDUCTION; BONE DEFECT; BONE IMPLANT; BONE MARROW STROMA CELL; BONE REGENERATION; BONE TISSUE; CELL CULTURE; CELL DIFFERENTIATION; CELL METABOLISM; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CELLS BY BODY ANATOMY; CHEMICAL INTERACTION; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL PROTOCOL; CONCENTRATION PROCESS; CONTROLLED STUDY; CRYOGEL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MONOCULTURE; NONHUMAN; OSTEOBLAST; PHENOTYPIC VARIATION; PHYSIOLOGICAL PROCESS; PROTEIN CONTENT; RAT; ANIMAL; BONE; BOVINE; CELL SHAPE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; IMPLANT; MATERIALS TESTING; MESENCHYMAL STROMA CELL; METABOLISM; PHARMACOLOGY; PHYSIOLOGY; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SCAFFOLD; ULTRASTRUCTURE; WISTAR RAT; YOUNG MODULUS;

ALKALINE PHOSPHATASE; ANIMALS; BIOCOMPATIBLE MATERIALS; BONE AND BONES; BONE REGENERATION; CATTLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SHAPE; CELLS, CULTURED; COLLAGEN; CRYOGELS; DURAPATITE; ELASTIC MODULUS; IMPLANTS, EXPERIMENTAL; MALE; MATERIALS TESTING; MESENCHYMAL STROMAL CELLS; OSSEOINTEGRATION; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE SCAFFOLDS;

EID: 84983098260     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.35540     Document Type: Article

References (37)

1. Bolgen N, et al., Three-dimensional ingrowth of bone cells within biodegradable cryogel scaffolds in bioreactors at different regimes. Tissue Eng Part A 2008; 14: 1743-1750.
2. Liu XH, Ma PX., Polymeric scaffolds for bone tissue engineering. Annals Biomed Eng 2004; 32: 477-486.
3. Seal BL, Otero TC, Panitch A., Polymeric biomaterials for tissue and organ regeneration. Mater Sci Eng R-Rep 2001; 34 (4-5): 147-230.
4. Langer R, Vacanti JP., Tissue engineering. Science 1993; 260: 920-926.
5. Vacanti JP., Tissue and organ engineering: Can we build intestine and vital organs? J Gastrointestinal Surg 2003; 7: 831-835.
6. Venugopal J, et al., Biocomposite nanofibres and osteoblasts for bone tissue engineering. Nanotechnology 2007; 18.
7. Horwitz EM., Marrow mesenchymal cell transplantation for genetic disorders of bone. Cytotherapy 2001; 3: 399-401.
8. Newman RE, et al., Treatment of inflammatory diseases with mesenchymal stem cells. Inflammation Allergy Drug Targets 2009; 8: 110 -1 23.
9. Liu YK, et al., In vitro effects of nanophase hydroxyapatite particles on proliferation and osteogenic differentiation of bone marrow-derived mesenchymal stem cells. J Biomed Mater Res Part A 2009; 90: 1083-1091.
10. Rodrigues SC, et al., Preparation and characterization of collagen-nanohydroxyapatite biocomposite scaffolds by cryogelation method for bone tissue engineering applications. J Biomed Mater Res Part A 2013; 101A: 1080-1094.
11. Kokubo T, et al., Solutions able to reproduce invivo surface-structure changes in bioactive glass-ceramic a-w3. J Biomed Mater Res 1990; 24: 721-734.
12. Lighezan R, et al., The value of the reprocessing method of paraffin-embedded biopsies for transmission electron microscopy. Romanian J Morphol Embryol 2009; 50: 613-617.
13. Torres FG, et al., Mechanical properties and bioactivity of porous PLGA/TiO(2) nanoparticle-filled composites for tissue engineering scaffolds. Compos Sci Technol 2007; 67: 1139-1147.
14. Alves NM, et al., Designing biomaterials based on biomineralization of bone. J Mater Chem 2010; 20: 2911-2921.
15. Malafaya PB, et al., Morphology, mechanical characterization and in vivo neo-vascularization of chitosan particle aggregated scaffolds architectures. Biomaterials 2008; 29: 3914-3926.
16. Qi HL, et al., Identification of genes responsible for osteoblast differentiation from human mesodermal progenitor cells. Proc Natl Acad Sci USA 2003; 100: 3305-3310.
17. Tommila M, et al., Bioactive glass-derived hydroxyapatite-coating promotes granulation tissue growth in subcutaneous cellulose implants in rats. Acta Biomaterialia 2008; 4: 354-361.
18. Ou KL, et al., Effects of the nanostructure and nanoporosity on bioactive nanohydroxyapatite/reconstituted collagen by electrodeposition. J Biomed Mater Res Part A 2010; 92: 906-912.
19. Laranjeira MS, Fernandes MH, Monteiro FJ., Response of monocultured and co-cultured human microvascular endothelial cells and mesenchymal stem cells to macroporous granules of nanostructured-hydroxyapatite agglomerates. J Biomed Nanotechnol 2013; 9: 1594-1606.
20. Komori T., Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res 2010; 339: 189-195.
21. Neve A, Corrado A, Cantatore FP., Osteoblast physiology in normal and pathological conditions. Cell Tissue Res 2011; 343: 289-302.
22. Yamaguchi A, et al., Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 1991; 113: 681-687.
23. Hauschka PV, et al., Osteocalcin and matrix gla protein-vitamin K-dependent proteins in bone. Physiol Rev 1989; 69: 990-1047.
24. Owen TA, et al., Progressive development of the rat osteoblast phenotype invitro-Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular-matrix. J Cell Physiol 1990; 143: 420-430.
25. Chenu C, et al., Osteocalcin induces chemotaxis, secretion of matrix proteins, and calcium-mediated intracellular signaling in human osteoclast-like cells. J Cell Biol 1994; 127: 1149-1158.
26. Lian J, et al., Structure of the rat osteocalcin gene and regulation of vitamin-d-dependent expression. Proc Natl Acad Sci USA 1989; 86: 1143-1147.
27. Lacey DL, et al., Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998; 93: 165-176.
28. Salasznyk RM, et al., Focal adhesion kinase signaling pathways regulate the osteogenic differentiation of human mesenchymal stem cells. Exp Cell Res 2007; 313: 22-37.
29. Yokoyama A, et al., Biomimetic porous scaffolds with high elasticity made from mineralized collagen-An animal study. J Biomed Mater Res Part B-Appl Biomater 2005; 75: 464-472.
30. Lee HR, et al., Comparative characteristics of porous bioceramics for an osteogenic response in vitro and in vivo. Plos One 2013; 8.
31. Anderson JM., Biological responses to materials. Annual Rev Mater Res 2001; 31: 81-110.
32. Baskin JZ, et al., Nanophase bone substitute in vivo response to subcutaneous implantation. J Biomed Mater Res Part A 2012; 100: 2462-2473.
33. Yoshikawa T, Ohgushi H, Tamai S., Immediate bone forming capability of prefabricated osteogenic hydroxyapatite. J Biomed Mater Res 1996; 32: 481-492.
34. Mate-Sanchez de Val JE, et al., Comparison of three hydroxyapatite/beta-tricalcium phosphate/collagen ceramic scaffolds: An in vivo study. J Biomed Mater Res Part A 2014; 102: 1037 -10 46.
35. Liu HH, et al., The promotion of bone regeneration by nanofibrous hydroxyapatite/chitosan scaffolds by effects on integrin-BMP/Smad signaling pathway in BMSCs. Biomaterials 2013; 34: 4404-4417.
36. Lopez MJ;, Daigle PR., Adult multipotent stromal cell technology for bone regeneration: A review. Vet Surg 2013; 42: 1-11.
37. Ankrum J;, Karp JM., Mesenchymal stem cell therapy: Two steps forward, one step back. Trends Mol Med 2010; 16: 203-209.